APOC1 and hepatocellular carcinoma: Similarly, the abundance of the APOC1+ macrophages was comparatively higher in HCC tissues, inhibiting APOC1 improves the effects of anti-PD-1 therapy by reshaping M2 macrophages into the M1 macrophages (168).